Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13

Apyx Medical will release its fourth quarter and fiscal year 2024 financial results on March 13, 2025, with a conference call.

Quiver AI Summary

Apyx Medical Corporation announced that it will release its financial results for the fourth quarter and fiscal year 2024 on March 13, 2025, before market opening. Management plans to hold a conference call at 8:30 a.m. Eastern Time on the same day to discuss these results and conduct a Q&A session. Interested parties can participate by phone or through a live webcast available on the company's website. Apyx Medical is known for its proprietary helium plasma and radiofrequency technology, branded as Renuvion, which is utilized in cosmetic and surgical markets, supported by extensive clinical research. For more information, the company's website can be visited.

Potential Positives

Apyx Medical is set to release its financial results for the fourth quarter and fiscal year 2024, signaling transparency and engagement with investors.
The scheduled conference call provides an opportunity for direct communication between management and stakeholders, enhancing investor relations.
The mention of over 90 clinical documents supporting the effectiveness of Renuvion and J-Plasma strengthens the company's credibility and market positioning in the cosmetic and surgical sectors.

Potential Negatives

The announcement does not provide any financial projections or expectations for the fourth quarter and fiscal year 2024, which may raise concerns among investors about transparency and future performance.
There is no mention of specific achievements or milestones reached during the year, which could imply that the company may not have made significant progress.
Potential reliance on a conference call to reveal crucial financial outcomes may lead to increased scrutiny and speculation if the results are not favorable.

FAQ

When will Apyx Medical announce its financial results for 2024?

Apyx Medical will release its financial results for the fourth quarter and fiscal year 2024 on March 13th, 2025.

What time is the Apyx Medical conference call?

The conference call will be held at 8:30 a.m. Eastern Time on March 13th, 2025.

How can I listen to the Apyx Medical earnings call?

You can listen by phone at 877-407-9039 or through the live webcast on Apyx Medical's Investor Relations website.

What products does Apyx Medical offer?

Apyx Medical offers Renuvion and J-Plasma, which utilize helium plasma technology for cosmetic and surgical procedures.

Who should I contact for investor relations at Apyx Medical?

For investor relations, contact Jeremy Feffer at LifeSci Advisors via phone at 212-915-2568 or email [email protected].

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$APYX Hedge Fund Activity

We have seen 16 institutional investors add shares of $APYX stock to their portfolio, and 26 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NANTAHALA CAPITAL MANAGEMENT, LLC added 3,169,800 shares (+inf%) to their portfolio in Q4 2024, for an estimated $5,008,284
PERCEPTIVE ADVISORS LLC added 150,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $237,000
RATHBONES GROUP PLC removed 150,000 shares (-59.7%) from their portfolio in Q4 2024, for an estimated $237,000
KESTRA ADVISORY SERVICES, LLC removed 124,189 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $196,218
RPG FAMILY WEALTH ADVISORY, LLC removed 75,250 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $118,895
CITADEL ADVISORS LLC added 53,782 shares (+427.8%) to their portfolio in Q4 2024, for an estimated $84,975
TAYLOR FRIGON CAPITAL MANAGEMENT LLC removed 51,128 shares (-8.6%) from their portfolio in Q4 2024, for an estimated $80,782

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

CLEARWATER, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Apyx ^® Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ^® , today announced that financial results for the fourth quarter and fiscal year 2024 will be released before the market opens on Thursday, March 13th.

Management will host a conference call at 8:30 a.m. Eastern Time on Thursday, March 13th to discuss the results of the fourth quarter and fiscal year 2024, and to host a question-and-answer session. To listen to the call by phone, interested parties may dial 877-407-9039 (or 201-689-8470 for international callers) and provide access code 13751519. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call will be accessible via the following link: Apyx Medical Earnings Webcast and via the Investor Relations section of the Company’s website, where it will be archived for future reference.

Investor Relations Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
OP: 212-915-2568
[email protected]

About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma ^® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com .